Finrozole

Finrozole
Names
	Preferred IUPAC name 4-[(1R,2S)-3-(4-Fluorophenyl)-2-hydroxy-1-(1H-1,2,4-triazol-1-yl)propyl]benzonitrile
Identifiers
CAS Number	160146-17-8 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL2218882;
ChemSpider	5293483;
ECHA InfoCard	100.219.051
PubChem CID	6918277;
UNII	40028KHQ6B ;
CompTox Dashboard (EPA)	DTXSID90166806 ;
	InChI InChI=1S/C18H15FN4O/c19-16-7-3-13(4-8-16)9-17(24)18(23-12-21-11-22-23)15-5-1-14(10-20)2-6-15/h1-8,11-12,17-18,24H,9H2/t17-,18+/m0/s1 Key: SLJZVZKQYSKYNV-ZWKOTPCHSA-N;
	SMILES C1=CC(=CC=C1C[C@@H]([C@@H](C2=CC=C(C=C2)C#N)N3C=NC=N3)O)F;
Pharmacology
ATCvet code	QG03XX90 (WHO)
Legal status	EU: Rx-only;
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Finrozole is an aromatase (CYP19A1) inhibitor.^[2]

Quick facts Names, Identifiers ...

Close

Finrozole was authorized for veterinary use in the European Union in April 2025.^[1]

Medical uses